Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0O1UC
|
|||
| Former ID |
DNCL001828
|
|||
| Drug Name |
NTC-801
|
|||
| Indication | Atrial fibrillation [ICD-11: BC81.3; ICD-10: I48] | Discontinued in Phase 1 | [1] | |
| Atrial flutter [ICD-11: BC81.2Z] | Discontinued in Phase 1 | [1] | ||
| Company |
Bristol-Myers Squibb; Nissan Chemical; Teijin Pharma
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Potassium channel unspecific (KC) | Target Info | Inhibitor | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800023917) | |||
| REF 2 | Effects of the selective KACh channel blocker NTC-801 on atrial fibrillation in a canine model of atrial tachypacing: comparison with class Ic and III drugs. J Cardiovasc Pharmacol. 2014 May;63(5):421-7. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.